Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252577 · ClinicalTrials.gov registry record
Genetic Predictors of Lithium Response in Bipolar Disorder
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 130
- Enrollment target
NCT00252577: Completed study, sponsored by VA Office of Research and Development.
NCT00252577 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252577 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
Interventions
- DRUG Lithium treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2005-10 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00252577
The ClinicalTrials.gov registry entry for NCT00252577 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lithium treatment is the first listed.
NCT00252577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00252577 about?
NCT00252577 is a clinical study titled "Genetic Predictors of Lithium Response in Bipolar Disorder". The purpose of this study is to identify genetic predictors of lithium response in bipolar disorder.
What is the current status of trial NCT00252577?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2005-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00252577?
The interventions under investigation include: Lithium treatment (DRUG).
Who is sponsoring clinical trial NCT00252577?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.